HPV 6, 11, 16, 18- attributable fraction of total lifetime costs per diagnosis.

‡Respiratory recurrent papillomatosis (RRP).
Italian data not available. The mean prevalence rates reported by the reference were informed by the outcomes of an ongoing metanalysis on global data compiled by he Unit of Infections and Cancer at the Istitut Catala d'Oncologia. No confidence intervals for the reported mean values were given.